Patients with lupus nephritis complicated by thrombotic microangiopathy tend to have high death risk and poor renal outcomes. They need vital and effective therapies.

Afghan children walk past a damaged car after an overnight Pakistani airstrike at the Balish village in Urgun district, Paktika Province, on February 22, 2026. (AFP) Pakistan Attack on Afghanistan: ...

Upholding the rule of law and alliances with like-minded states provide a regional safeguard against aggression, Luxembourg’s deputy Prime Minister Xavier Bettel said Wednesday, as he sought closer ...

Sanofi SNY announced that the FDA has granted Breakthrough Therapy designation to Wayrilz (rilzabrutinib), a novel oral, reversible Bruton’s tyrosine kinase (BTK) inhibitor, for the treatment of ...

Sanofi’s rilzabrutinib designated breakthrough therapy in the US and orphan drug in Japan for the treatment of warm autoimmune hemolytic anemia Rilzabrutinib is the first and only investigational BTKi ...

Sanofi’s investigational therapy rilzabrutinib has received breakthrough therapy designation from the FDA for the treatment of warm autoimmune hemolytic anemia. The designation is based on data from ...

Dueling polls. New ads. Uncertain momentum. Our panel breaks down the Crockett–Talarico primary battle. Trump faces fresh MAGA blowback for efforts to 'de-escalate' in Minnesota Weight-loss drugs draw ...

SOUTH SAN FRANCISCO, Calif., Jan. 20, 2026 /PRNewswire/ -- Ouro Medicines, a clinical stage biotechnology company developing immune reset therapeutics for people living with chronic, immune-mediated ...

CNBC's Rick Santelli joins 'Squawk on the Street' to break down the latest economic data to cross the tape. Denmark facing "decisive moment" over Trump Greenland threat NFL playoff winners and losers: ...

A phase 3 trial of Hutchmed’s autoimmune disease candidate sovleplenib has hit its primary endpoint, delivering a boost to an asset that was held up by quality issues in another indication. Hong ...

Immune thrombocytopenia (ITP), previously called idiopathic thrombocytopenic purpura, is a rare blood disorder where your body’s immune system attacks and destroys your platelets. Platelets help form ...